Achieving Conduction System Activation With Leadless Left Ventricular Endocardial Pacing
Launched by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST · Dec 19, 2022
Trial Information
Current as of April 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 18 years
- • Ability to provide informed consent to participate and willing to comply with the clinical investigation plan and follow-up schedule.
- * Patients meeting European Society of Cardiology Criteria for Cardiac Resynchronization Therapy (CRT) with Class 1 or 2a recommendation:
- • Dyssynchronous Heart Failure: Left Ventricular Ejection Fraction (LVEF) ≤35%, QRS duration \>150ms or \>130ms in presence of left bundle branch block (LBBB). Also included here are patients with EF ≤35%, an existing pacing system and an RV pacing burden of \>20%.
- • BLOCK HF population: Patients requiring pacing for atrioventricular (AV) block with an LVEF ≤50%
- • AV node ablation (AVNA) population: Patients planned for AVNA with EF ≤50%.
- Exclusion Criteria:
- • Any contraindication to LV endocardial pacing.
- • LV thrombus
- • Contra-indication to heparin
- • Contra-indication to anti-platelet agents
- • Failure of acoustic window screening
- • Septal wall thickness \<5mm (minimum required wall thickness at any target implant site)
- • Myocardial infarction within 40 days prior to enrolment.
- • Cardiac surgery or coronary revascularisation procedure within 3 months prior to enrolment or to be scheduled for such procedures within the following 7 months.
- • Participation in other studies with active treatment/investigational arm.
- • Pregnant or planning to become pregnant in the next 7 months.
About Guy's And St Thomas' Nhs Foundation Trust
Guy's and St Thomas' NHS Foundation Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and clinical excellence. As a prominent academic health science center, the Trust integrates cutting-edge research with clinical practice, facilitating the translation of scientific discoveries into improved treatment options. With a diverse portfolio of clinical trials across various medical specialties, Guy's and St Thomas' NHS Foundation Trust plays a pivotal role in advancing healthcare knowledge and enhancing patient outcomes, while maintaining the highest ethical standards in research and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials